Entera Bio Ltd. (ENTX): מחיר לרווח מתואם קצב צמיחה
The P/E ratio relative to the company's growth rate is provided by the GURU.Markets service, with the value holding at 0.00. Entera Bio Ltd. (ENTX) is integrating ESG standards into its production, optimizing waste disposal and bioethics. The firm has developed a unique platform for the oral administration of hormones for osteoporosis. Current quotes price in the success of tests, while future growth depends on new partnerships.
פילוחי מדדים ואנליטיקה של חברת Entera Bio Ltd. (ENTX)
The indicator is calculated by dividing the P/E ratio by the annual earnings growth rate. This metric determines the fair value of an asset by adjusting the market valuation for business expansion dynamics. For Entera Bio Ltd. (ENTX), such calculations are critical, as military risks in Israel may artificially depress the company's valuation. By analyzing the P/E to EPS growth ratio, an investor can identify undervalued "rockets." Values below one signal growth potential.
